Safety and Immunogenicity of CVI-VZV-001 in Adults Aged 50 Years and Above

NCT07481604 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

135

Enrollment

INDUSTRY

Sponsor class

Conditions

Herpes Zoster

Interventions

BIOLOGICAL: Shingrix
BIOLOGICAL: CVI-VZV-001

Sponsor

CHA Vaccine Institute Co., Ltd.